UDCA modulates the interaction between the Bcl-2/Beclin-1 complex and the Bcl-2/Bax complex through activation of the AMPK pathway, thereby inducing autophagy and impeding the progression of NAFLD. Here, BCL2 is linked to metabolic dysfunction-associated steatotic liver disease.